Gadkari reviews Monsoon Preparedness for Safer Highways (See 'Corp Brief') Skymap Pharmaceuticals approved as Strategic Buyer for disinvestment of IMPCL (See 'Corp Brief') A&C - SpiceJet is directed to deposit outstanding amount immediately while also applying costs: HC (See 'Legal Desk') PM-WANI Ecosystem undergoes Comprehensive Transformation to enable Inclusive Digital Connectivity (See 'Corp Brief') Sales of Khadi and Village Industry Products surpasses Rs 1.87 Lakh Crore-mark (See 'Corp Brief') SARFAESI - Suit's substantive reliefs concern specific performance and enforcement of agreements, plaint cannot be rejected at threshold under Order VII Rule 11 CPC merely because SARFAESI measures are also in background: HC (See 'Legal Desk') Reddy directs Agencies to Fast-Track Pending Mining & Exploration Projects (See 'Corp Brief') Meghalaya Minister discusses STI Hubs for Tribal Communities in Northeast with MoS (See 'Corp Brief') Govt strengthening Preventive Healthcare through Yoga and Naturopathy: Jadhav (See 'Corp Brief') Gadkari reviews NH Projects in Rajasthan and HP (See 'Corp Brief') Secretary reviews Progress of Mineral Block Auctions and Operationalisation (See 'Corp Brief') FERA - Receipt by person in India of Indian currency through cheque drawn on NRE account, even if that account had been funded by foreign currency deposits, does not by itself constitute contravention of Sec 8(1): HC (See 'Legal Desk') Parcel and Logistics Services register 70% growth; Revenue Potential pegged at Rs.10,000 Crore (See 'Corp Brief') Department of Consumer Affairs holds stakeholder meeting on Different Pack Sizes for Edible Oils (See 'Corp Brief') 'Spice and Heal' Initiative can Position India as Global Wellness Leader: Jadhav (See 'Corp Brief') Competition Act - Allegations relating to use of unlicensed/private vehicles & regulatory violations is not competition law issue u/s 3 and 4 of Competition Act: CCI (See 'Legal Desk') Moratorium under the IBC (See CORP EINSICHT) NMDC launches Summer Camp for 1700 Children in Dakshin Bastar (See 'Corp Brief') Benami Act - Confiscation under Benami Act is civil consequence and distinct from prosecution: SC (See 'Legal Desk') 'Janjati Samagam' will, in coming years, gain global recognition as Kumbh of tribal communities (See 'Corp Brief') At Siliguri's 19th employment fair, 82 young people receive appointment letters (See 'Corp Brief') IBC - During subsistence of moratorium u/s 14 IBC, lessor cannot terminate subsisting lease and recover possession of leased property occupied by corporate debtor by invoking contractual breach clauses: HC (See 'Legal Desk')

Skymap Pharmaceuticals approved as Strategic Buyer for disinvestment of IMPCL

Published: May 27, 2026

By TIOLCorplaws News Service

NEW DELHI, MAY 27, 2026: THE Alternative Mechanism, a Group of Ministers empowered by the Cabinet Committee on Economic Affairs, comprising Union Cabinet Minister for Road Transport and Highways, Union Cabinet Minister for Finance and Union Minister of State (Independent Charge) for Ministry of AYUSH, have approved the highest bid amounting to Rs. 121,00,94,400 (One Hundred Twenty One Crores Ninety Four Thousand Four Hundred only) of M/s. Skymap Pharmaceuticals Private Limited for the sale of 100% equity shareholding of Indian Medicines Pharmaceutical Corporation Limited (IMPCL) along with transfer of management control.

IMPCL was incorporated on July 12, 1978 with the prime objective of manufacturing and supplying standardised Ayurvedic and Unani Medicines. CCEA granted 'in-principle' approval in November, 2017 for the strategic disinvestment of entire equity shareholding of IMPCL to a strategic buyer to be identified through a two-stage bidding process.

Following a competitive bidding process, professional advisers (Transaction Adviser, Legal Adviser, Asset Valuer) were appointed for the transaction. The Preliminary Information Memorandum (PIM) inviting Expression of Interest (EoI) from prospective bidders was issued on 01.09.2023, in response to which, 07 Interested Parties expressed interest, all of which were shortlisted as qualified bidders. Post-shortlisting, Qualified Interested Bidders (QIBs) conducted due diligence and the security clearance was obtained from the MHA.

The Request for Proposal (RFP) along with Share Purchase Agreement (SPA) containing terms and conditions were issued on 01.12.2025 inviting technical and financial bids. Two sealed financial bids were received from the QIBs in response thereof, by the due date 20.01.2026. Both the bids were evaluated as per the prescribed procedure and found to be technically qualified. Thereafter, the technically qualified financial bids were opened in the presence of the representatives of the bidders. M/s. Skymap Pharmaceuticals Pvt. Ltd. emerged as the highest bidder at Rs. 121,00,94,400 (One Hundred Twenty-One Crores Ninety-Four Thousand Four Hundred only), which was also above the reserve price. 

The strategic disinvestment transaction was implemented through a two-stage open, competitive bidding process supported by a multi-layered consultative decision-making mechanism involving Inter-Ministerial Group, Core Group of Secretaries on Disinvestment and the empowered Alternative Mechanism. The Letter of Award has been issued to the Successful Bidder. Secretary, DIPAM and Secretary, AYUSH have been authorised to complete and close the transaction as early as possible.

TIOL CORP SEARCH

TIOL GROUP WEBSITES